PTC
EOLS icon

Private Trust Company’s Evolus EOLS Stock Holding History

Private Trust Company’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,558
Closed -$43.6K – 2633
2025
Q4 		$43.6K Hold
6,558
– – ﹤0.01% 1350
2025
Q3 		$40.3K Hold
6,558
– – ﹤0.01% 1366
2025
Q2 		$60.4K Sell
6,558
-85
-1% -$870 0.01% 1136
2025
Q1 		$79.9K Buy
6,643
+85
+1% +$1.11K 0.01% 1015
2024
Q4 		$72.4K Hold
6,558
– – 0.01% 1038
2024
Q3 		$106K Hold
6,558
– – 0.01% 899
2024
Q2 		$71.2K Hold
6,558
– – 0.01% 991
2024
Q1 		$91.8K Hold
6,558
– – 0.01% 898
2023
Q4 		$69.1K Sell
6,558
-5,000
-43% -$44.7K 0.01% 956
2023
Q3 		$106K Hold
11,558
– – 0.01% 776
2023
Q2 		$84K Hold
11,558
– – 0.01% 863
2023
Q1 		$97.8K Hold
11,558
– – 0.01% 777
2022
Q4 		$87K Hold
11,558
– – 0.01% 779
2022
Q3 		$93K Hold
11,558
– – 0.02% 699
2022
Q2 		$134K Buy
+11,558
New +$136K 0.02% 596

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Trust Company's EOLS Position: Q1 2026 in Review

Private Trust Company sold out of Evolus (EOLS) in Q1 2026, closing a stake of 6,558 shares — an estimated $43.6K sold.

Private Trust Company first reported a position in EOLS in Q2 2022 and held it in 15 quarters. The position peaked at $134K in Q2 2022. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Private Trust Company reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • Private Trust Company sold 6,558 Evolus shares in Q1 2026, an estimated $43.6K.
  • Private Trust Company first reported a position in Evolus in Q2 2022 and held it in 15 quarters.
  • Private Trust Company's Evolus position peaked at $134K in Q2 2022.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.